Wendy Carruthers net worth and biography

Wendy Carruthers Biography and Net Worth

SVP of Boston Scientific

Wendy Carruthers is our senior vice president, human resources, a position she has held since December 2012. In this role, she is responsible for overseeing the Company’s human resources activities globally, including human resources operations and services, total rewards, talent management, diversity and inclusion and community engagement. Prior to her current role, Ms. Carruthers served as the head of human resources on an interim basis from August 2012 to November 2012, as well as our vice president of global talent management from January 2011 to November 2012. Ms. Carruthers has been with Boston Scientific since 2004 and has held various positions such as, vice president of human resources for our Europe, Middle East and Africa region; vice president of human resources for Europe and director of human resources for Europe. Also, Ms. Carruthers serves as a Co-Chair of our Global Council for Inclusion. Prior to joining Boston Scientific, Ms. Carruthers was vice president of human resources, Europe for Cable & Wireless. Ms. Carruthers holds a B.A. First Class Honors Degree in Modern Languages from the University of Salford and is a Fellow of the Chartered Institute of Personnel and Development. She serves on the Board of Envista Holdings Corporation and the Boston Scientific Foundation, and she is a member of the Greater Boston Food Bank Emeriti Board.

What is Wendy Carruthers' net worth?: The estimated net worth of Wendy Carruthers is at least $2.61 million as of December 2nd, 2024. Ms. Carruthers owns 29,308 shares of Boston Scientific stock worth more than $2,606,947 as of December 21st. This net worth estimate does not reflect any other assets that Ms. Carruthers may own. Learn More about Wendy Carruthers' net worth.
How do I contact Wendy Carruthers?: The corporate mailing address for Ms. Carruthers and other Boston Scientific executives is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. Boston Scientific can also be reached via phone at (508) 683-4000 and via email at [email protected]. Learn More on Wendy Carruthers' contact information.
Has Wendy Carruthers been buying or selling shares of Boston Scientific?: During the last ninety days, Wendy Carruthers has sold $1,219,511.12 in shares of Boston Scientific stock. Most recently, Wendy Carruthers sold 6,983 shares of the business's stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $90.78, for a transaction totalling $633,916.74. Following the completion of the sale, the executive vice president now directly owns 29,308 shares of the company's stock, valued at $2,660,580.24. Learn More on Wendy Carruthers' trading history.
Who are Boston Scientific's active insiders?: Boston Scientific's insider roster includes Kevin Ballinger (EVP), Supratim Bose (EVP), Daniel Brennan (CFO), Vance Brown (SVP), Arthur Butcher (EVP), Wendy Carruthers (SVP), Nelda Connors (Director), Keith Dawkins (EVP), Charles Dockendorff (Director), Jodi Eddy (SVP), Joseph Fitzgerald (EVP), Edward Ludwig (Director), Edward Ludwig (Director), Edward Mackey (EVP), Michael Mahoney (CEO), Ian Meredith (EVP), Jeffrey Mirviss (EVP), Jonathan Monson (CAO), Maulik Nanavaty (SVP), Scott Olson (SVP), Michael Phalen (EVP), David Pierce (EVP), Timothy Pratt (EVP), Desiree Ralls-Morrison (SVP), Meghan Scanlon (SVP), John Sorenson (SVP), Eric Thepaut (EVP), Xin Wang (SVP), and David Wichmann (Director). Learn More on Boston Scientific's active insiders.
Are insiders buying or selling shares of Boston Scientific?: During the last twelve months, insiders at the medical equipment provider sold shares 23 times. They sold a total of 507,193 shares worth more than $40,282,850.73. The most recent insider tranaction occured on December, 2nd when EVP Wendy Carruthers sold 6,983 shares worth more than $633,916.74. Insiders at Boston Scientific own 0.5% of the company. Learn More about insider trades at Boston Scientific.
Information on this page was last updated on 12/2/2024.

Wendy Carruthers Insider Trading History at Boston Scientific

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/2/2024	Sell	6,983	$90.78	$633,916.74	29,308
10/1/2024	Sell	6,983	$83.86	$585,594.38	34,748
9/3/2024	Sell	6,983	$81.70	$570,511.10	37,468
8/1/2024	Sell	6,983	$74.12	$517,579.96	40,188
7/1/2024	Sell	6,983	$77.30	$539,785.90	42,908
6/3/2024	Sell	6,983	$75.33	$526,029.39	45,628
3/1/2024	Sell	6,983	$66.35	$463,322.05	53,788
2/23/2024	Sell	6,983	$66.89	$467,092.87	56,508
10/16/2023	Sell	11,671	$49.79	$581,099.09	51,795
9/15/2023	Sell	11,671	$53.95	$629,650.45	57,058
8/15/2023	Sell	11,671	$51.30	$598,722.30	62,321
7/17/2023	Sell	11,671	$52.85	$616,812.35	67,584
6/15/2023	Sell	11,671	$53.24	$621,364.04	72,847
4/17/2023	Sell	11,671	$51.96	$606,425.16	83,373
12/15/2022	Sell	7,500	$46.62	$349,650.00	87,413
11/15/2022	Sell	1,678	$42.60	$71,482.80	94,913
10/17/2022	Sell	13,322	$40.52	$539,807.44	96,591
9/15/2022	Sell	7,500	$42.21	$316,575.00	109,913
8/15/2022	Sell	7,500	$42.03	$315,225.00	117,413
7/18/2022	Sell	7,500	$38.00	$285,000.00	124,913
6/24/2022	Sell	7,500	$38.00	$285,000.00	132,413
5/16/2022	Sell	7,500	$39.43	$295,725.00	139,913
4/14/2022	Sell	7,500	$44.47	$333,525.00	147,413
12/15/2021	Sell	3,321	$40.83	$135,596.43
11/15/2021	Sell	3,321	$42.18	$140,079.78
10/15/2021	Sell	3,322	$43.58	$144,772.76
9/15/2021	Sell	3,321	$44.88	$149,046.48	164,573
7/15/2021	Sell	3,321	$42.42	$140,876.82	171,216
6/15/2021	Sell	3,322	$42.70	$141,849.40	174,537
8/26/2020	Sell	10,200	$39.16	$399,432.00	178,973
12/13/2019	Sell	24,220	$45.03	$1,090,626.60	168,848
3/11/2019	Sell	29,412	$39.63	$1,165,597.56	200,751
11/2/2018	Sell	1,500	$36.64	$54,960.00
8/3/2017	Sell	12,433	$26.75	$332,582.75
5/28/2015	Sell	42,281	$17.91	$757,252.71
5/30/2013	Sell	25,001	$9.16	$229,009.16

Wendy Carruthers Buying and Selling Activity at Boston Scientific

Boston Scientific Company Overview

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Today's Range

Now: $88.95

$87.25

$89.67

50 Day Range

MA: $88.31

$83.62

$91.54

2 Week Range

Now: $88.95

$54.96

$91.93

Volume

15,881,501 shs

Average Volume

6,000,576 shs

Market Capitalization

$131.10 billion

P/E Ratio

73.51

Dividend Yield

N/A

Beta

0.8

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now